Bisaro Paul
SEC-identified person · CIK 1237253 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Myriad Genetics INC MYGN | Director | filed 2022–2026 |
| Mallinckrodt plc MNKTQ | Director | filed 2022–2026 |
| Zoetis Inc. ZTS | Director | filed 2015–2026 |
| Therapeuticsmd, Inc. coff | Director | filed 2020–2022 |
| Amneal Pharmaceuticals, Inc. AMRX | Director · Executive Chairman | filed 2018–2019 |
| Impax Laboratories, LLC IPXL.OB | Director · President and CEO | filed 2017–2018 |
| Allergan plc AGN | Director · Exec Chairman | filed 2013–2018 |
| Zimmer Holdings INC ZMH | Director | filed 2013–2017 |
| Watson Pharmaceuticals INC WPI | Director · President & CEO | filed 2007–2013 |
| Barr Pharmaceuticals INC BRL | Director · President & COO | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.